Aeromonas: How Waterborne Bacteria Cause Human Infections

Aeromonas is a genus of gram-negative bacteria that thrives in freshwater environments worldwide and causes disease in both fish and humans. While it has been recognized for decades as a devastating pathogen in aquaculture, its role in human illness has been harder to pin down. Some species cause unmistakable gastroenteritis or dangerous wound infections, yet the same bacteria turn up in the stools of perfectly healthy people, blurring the line between pathogen and harmless bystander. That ambiguity, combined with rising antibiotic resistance and a warming climate, has pushed Aeromonas from a niche microbiological curiosity into a genuine public-health concern.

Where Aeromonas Lives

Aeromonas species are fundamentally aquatic organisms. They inhabit rivers, lakes, ponds, groundwater, and even treated drinking water. Surface water surveys in rural communities have found average counts in the thousands of colony-forming units per 100 milliliters, confirming that the bacteria are common residents of untreated freshwater sources.¹ They also colonize soil, sewage, and food, particularly raw fish and shellfish. The genus tolerates a wide range of temperatures, with some species growing at refrigeration temperatures and others flourishing in warm tropical water.

One reason Aeromonas persists so tenaciously in water systems is biofilm formation. Among freshwater isolates of A. veronii tested in one study, roughly 70% were classified as strong biofilm producers, and those biofilms resisted even aggressive chlorine treatment. After three hours of exposure to 10 mg/L free chlorine, the metabolic activity of most biofilms dropped by less than half, and some showed no measurable change compared to untreated controls.² That resilience matters for drinking-water safety. Standard disinfection may kill free-floating cells but leave biofilm-dwelling Aeromonas largely intact.

A Tangled Family Tree

Identifying which Aeromonas species you are dealing with is surprisingly difficult. The genus contains dozens of recognized species, many of them so genetically similar that traditional methods struggle to tell them apart. The 16S ribosomal RNA gene, the workhorse of bacterial identification, is highly conserved across the genus and offers limited ability to split closely related species.³ Researchers have turned to other housekeeping genes to get better resolution, and sequencing multiple genes has become the standard approach for improving the taxonomy of this notoriously messy genus.⁴

In clinical laboratories, a technology called MALDI-TOF mass spectrometry has become the go-to tool for rapid identification. It matches a bacterial protein fingerprint against a reference database and produces results in minutes. For Aeromonas, MALDI-TOF agreed with gene-sequencing results at the species level about 92% of the time in one evaluation, though it occasionally confused closely related species like A. caviae and A. hydrophila.⁵ An independent assessment reached a similar conclusion: MALDI-TOF is acceptably accurate, time-efficient, and cheap, even if it does not get every species right.⁶ Getting the species right matters because different species carry different virulence profiles, behave differently in the gut, and respond differently to antibiotics.

Human Gut Infections and the Commensal Puzzle

The most common way Aeromonas affects people is through gastroenteritis. In an Australian study using multiplex molecular diagnostics, Aeromonas ranked as the second most common bacterial cause of gut infections in patients with gastroenteritis and was the single most common bacterial enteric pathogen in children younger than 18 months.⁷ The typical presentation is watery diarrhea, often accompanied by fever and abdominal cramps, while nausea and vomiting tend to be less prominent. In a study of travelers’ diarrhea, half the patients had persistent diarrhea lasting beyond the acute phase.⁸

Here is where the picture gets murky. A study comparing symptomatic patients with Aeromonas-associated gastroenteritis (AAG) against asymptomatic individuals found that roughly 4 to 5% of symptomatic patients carried Aeromonas as the sole stool pathogen, but so did about 4.9% of people with no symptoms at all. Patients whose diarrhea was attributed to Campylobacter actually reported more severe symptoms than those with Aeromonas.⁹ The finding that Aeromonas turns up at similar rates in sick and healthy people makes it genuinely hard to know, in any individual case, whether the bacterium is the culprit or just a bystander. Clinicians dealing with a stool culture positive for Aeromonas often have to weigh the clinical context rather than treat the lab result in isolation.

Wound Infections and Necrotizing Fasciitis

Beyond the gut, Aeromonas can cause soft-tissue infections that range from mild cellulitis to life-threatening necrotizing fasciitis, the rapid-spreading “flesh-eating” disease. The classic scenario involves an open wound exposed to contaminated freshwater. In one published case, a patient developed necrotizing fasciitis from A. sobria after sustaining a skin injury in a lake.¹⁰ Another report described a patient who cut his foot mowing the lawn, then spent time in a pool contaminated with mold, and subsequently developed necrotizing fasciitis with septic shock.¹¹ Aeromonas-related necrotizing fasciitis carries a higher mortality than many other causes of the same condition, so any open wound that has been in contact with pond, lake, or river water warrants a high degree of suspicion.

Bloodstream Infections in Vulnerable Patients

When Aeromonas enters the bloodstream, the consequences can be severe. A study from southern Taiwan found that roughly half of patients with Aeromonas bacteremia were older than 65, and more than three-quarters had underlying immunocompromising conditions such as cancer, liver cirrhosis, or diabetes.¹² Liver disease appears to be a particularly strong risk factor. In a comparison of Aeromonas bacteremia with enterobacterial bacteremia in patients with liver cirrhosis, the one-month mortality was about 55% in the Aeromonas group, though the small sample size meant this was not statistically different from the roughly 42% mortality in the enterobacterial group.¹³ Either way, bloodstream Aeromonas infections are not something healthy people need to worry about, but for those with compromised immunity or chronic liver disease, these infections can be fatal.

How Aeromonas Causes Damage

Aeromonas species do not rely on a single weapon. They carry a sophisticated toolkit of virulence factors, and different species and strains deploy different combinations. The best-studied toxin is aerolysin, a pore-forming protein that punches holes in the membranes of host cells, killing them.¹⁴ This same protein has been called a “cytotoxic enterotoxin” in the literature, but the evidence points to it being aerolysin by another name. It lyses red blood cells, destroys cultured cells, triggers fluid secretion in the gut, and provokes a strong inflammatory response by stimulating immune cells to release proinflammatory signaling molecules.¹⁵

Beyond aerolysin, some Aeromonas species use specialized secretion systems to inject toxins directly into host cells. A. hydrophila employs a type VI secretion system to translocate an effector protein called VgrG1, which disrupts the cell’s internal skeleton by chemically modifying actin, ultimately killing the cell.¹⁶ Meanwhile, A. salmonicida, the major fish pathogen, uses a type III secretion system to deliver its own toxin into fish cells. When researchers disabled this system in a rainbow trout model, the mutant bacteria were swallowed up by immune cells and caused zero mortality, compared to 88% cumulative mortality in fish infected with the normal strain.¹⁷ That result underscores how essential these molecular injection systems are to the bacterium’s ability to cause systemic disease.

The Aquaculture Problem

For fish farmers, Aeromonas is one of the most economically damaging pathogens they face. A. salmonicida causes furunculosis, a systemic disease of salmon, trout, and other salmonids marked by high mortality and worldwide distribution.¹⁸ The warm-water counterpart is motile Aeromonas septicemia (MAS), caused primarily by A. hydrophila. MAS affects a wide variety of freshwater species including carp, tilapia, perch, and catfish. In 2009, a highly virulent strain of A. hydrophila emerged in commercially raised catfish in the southeastern United States, eventually spreading across Alabama, Mississippi, and Arkansas. Losses from that epidemic were estimated at more than $12 million.¹⁹ Research into that outbreak pointed to an Asian origin for the virulent strain, highlighting how global trade in live fish can move dangerous bacteria across continents.

Treating MAS in fish is complicated by antibiotic resistance. One study isolated a pathogenic A. hydrophila strain from common carp that was resistant to more than 13 different antimicrobial agents.²⁰ Some researchers have explored alternatives to antibiotics entirely. A quorum-quenching bacterium, Bacillus licheniformis T-1, interfered with the cell-to-cell communication signals that A. hydrophila uses to coordinate its virulence, achieving about 70% relative survival in zebrafish that were co-injected with both the pathogen and the protective strain.²¹ In another approach, feeding common carp a probiotic strain of A. veronii boosted their innate immunity and raised survival against A. hydrophila challenge from about 53% to over 90%.²² The fact that one Aeromonas species can serve as a probiotic against another captures the biological diversity packed into this single genus.

Antibiotic Resistance and Gene Sharing

Aeromonas species carry a worrying portfolio of antibiotic-resistance mechanisms, some of which they can hand off to other, more clinically dangerous bacteria. Many strains carry a chromosomal gene called cphA, which encodes a metallo-beta-lactamase that efficiently breaks down carbapenem antibiotics, the “last resort” drugs used in hospitals for hard-to-treat infections.²³ On top of that built-in resistance, Aeromonas isolates from wastewater and environmental samples have been found to carry additional carbapenemase genes on plasmids, the mobile DNA elements that bacteria swap between species.²⁴

The gene-sharing potential is not theoretical. Laboratory conjugation experiments have demonstrated that multidrug-resistant Aeromonas isolated from hospital wastewater can transfer plasmid-borne resistance genes, including genes for carbapenemase and tetracycline resistance, to E. coli and Salmonella through direct cell-to-cell contact.²⁵ A genomic comparison of hospital-wastewater Aeromonas versus clinical Aeromonas isolates found that wastewater strains carried dramatically expanded resistance gene arsenals, averaging about 14 resistance genes per genome compared to about 3 in clinical isolates. The wastewater strains also had more and larger plasmids, and researchers found extensive plasmid-backbone overlap between Aeromonas and other resistant bacteria recovered from the same samples.²⁶ In other words, hospital drains function as meeting places where Aeromonas can pick up resistance genes and pass them along to bacteria that are far more common causes of human infection.

The Leech Connection

One of the more unexpected places Aeromonas turns up is inside medicinal leeches. Leeches are still used in reconstructive and microsurgery to relieve venous congestion in tissue flaps, but they carry Aeromonas as a natural symbiont in their gut. When a leech feeds on a surgical wound, it can introduce the bacteria directly into the patient. Aeromonas infections are the most commonly reported complication of post-operative leech therapy, which is why prophylactic antibiotics are recommended before and during treatment.²⁷ In one series of 28 patients treated with a total of 595 leeches across plastic and orthopedic surgeries, three documented post-operative infections occurred.²⁸ Researchers have experimented with feeding the leeches antibiotics before use to try to eliminate the Aeromonas from their digestive tracts, a creative approach that highlights how deeply embedded the bacterium is in the leech’s biology.

Aeromonas in Food

A. hydrophila is classified as a psychrotrophic pathogen, meaning it can grow at cold temperatures that would slow or stop most bacteria. Experiments on refrigerated fish fillets showed that inoculated A. hydrophila grew steadily on both catfish and trout over a 15-day storage period, and the natural microbial flora on the fillets did nothing to inhibit it.²⁹ That ability to multiply in the fridge is relevant anywhere cross-contamination with ready-to-eat foods is possible. Thorough cooking kills Aeromonas, but the risk sits in the chain between purchase and plate, especially if raw fish juices drip onto foods that will not be heated before eating.

Climate Change and Expanding Risk

Warming freshwater temperatures are expected to worsen Aeromonas-related disease, particularly in aquaculture. Higher water temperatures increase the virulence of A. hydrophila, making outbreaks of hemorrhagic septicemia harder to control in farmed freshwater fish.³⁰ The mechanism is straightforward: warmer water supports faster bacterial growth and, for Aeromonas specifically, upregulates the production of virulence factors. Combined with the stress that elevated temperatures place on fish immune systems, the net result is more frequent and more severe outbreaks. For human health, the concern is less direct but still real. More Aeromonas in recreational and source water means more opportunities for wound infections in swimmers, more contamination of water supplies, and a growing role as an environmental reservoir of transferable antibiotic-resistance genes.

Genomic Plasticity and Emerging Species

Part of what makes Aeromonas a persistent concern is the sheer flexibility of its genome. Mobile genetic elements like transposons shuttle virulence and resistance genes in and out of the chromosome, allowing strains to adapt rapidly to new niches. A comparative genomic analysis of an environmental A. rivipollensis strain revealed unique virulence factors including genes for polysialic acid, which can help bacteria evade the immune system by mimicking host cell surfaces, and immunoglobulin A-binding proteins, which may interfere with the antibody response.³¹ These findings illustrate how environmental Aeromonas strains can independently acquire the genetic tools to cause trouble in hosts they have never encountered before. With new species and new virulence profiles still being described, the genus remains a moving target for microbiologists and public-health officials alike.